Indiana gets $1.1 million in settlement with Pfizer (PFE) over marketing of Zyvox, Lyrica

32 states, D.C. settle with drugmaker

INDIANAPOLIS - Indiana will receive $1.1 million in a settlement with Pfizer Inc. over its marketing of the drugs Zyvox and Lyrica.

Indiana Attorney General Greg Zoeller said Wednesday that the $1.1 million is Indiana's share of a $42.9 million settlement Pfizer reached to resolve allegations that the company unlawfully promoted those drugs.

Thirty-two states and the District of Columbia claimed that Pfizer used deceptive practices in marketing Zyvox, an antibacterial agent, and promoted off-label uses for Lyrica, which is used to treat fibromyalgia.

"Off-label marketing can put patients unnecessarily at risk," Zoeller said in a news release. "Pharmaceutical companies are required to only promote a prescription drug for uses that have been approved by the FDA."

Under the settlement, Pfizer is not admitting wrongdoing but said it will reform how it markets the drugs.

Print this article Back to Top